Who owns BillionToOne, Inc. (BLLN)? Elite investor 13F holders
3 tracked elite investors reported holding BillionToOne, Inc as of 2026-09-30, including D.E. Shaw, Renaissance Technologies LLC, Polen Capital Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Health Care Equipment & Services
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions,…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| D.E. Shaw | BILLIONTOONE INC | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 45588785.00 USD | 428305.000000 | Shares | add | Original filing |
| Renaissance Technologies LLC | BILLIONTOONE INC | SHARE | 2026-09-30 | 2026-11-12 00:00:00 | 19553028.00 USD | 183700.000000 | Shares | add | Original filing |
| Polen Capital Management | BILLIONTOONE INC | SHARE | 2026-09-30 | 2026-11-13 00:00:00 | 4563296.00 USD | 42872.000000 | Shares | add | Original filing |
| Gotham Asset Management | BILLIONTOONE INC | SHARE | 2026-09-30 | 2026-11-16 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.